Author | Sumanta Kumar Pal, MD | OncLive

Author | Sumanta Kumar Pal, MD

Articles

Dr. Pal on the Background of the COSMIC-021 Trial in ​Urothelial Cancer

June 24, 2020

Video

Sumanta K. Pal, MD, discusses the background of the COSMIC-021 trial in urothelial cancer.

Dr. Pal on the Potential Use of PARP Inhibitors in RCC

February 11, 2020

Video

Sumanta Kumar Pal, MD, discusses the potential use of PARP inhibitors in renal cell carcinoma.

Dr. Pal on CRISPR-Based Technology in RCC

October 04, 2019

Video

Sumanta Kumar Pal, MD, discusses potential developments with vaccines and CRISPR/Cas9 technology coming down the pipeline in renal cell carcinoma.

Dr. Pal on the Design of the SWOG 1500 Trial in Papillary RCC

July 23, 2019

Video

Sumanta Kumar Pal, MD, an associate clinical professor, Department of Medical Oncology & Therapeutics Research, co-director, Kidney Cancer Program, and medical oncologist at City of Hope, discusses the design of the phase II SWOG 1500 trial (NCT02761057) in locally advanced or metastatic papillary renal cell carcinoma (RCC).

x